ASIA News
WELT-I offers a six-week CBT programme to treat chronic insomnia.
It is making further moves to penetrate the Southeast Asian market.
They will deploy AI to help reduce delays and gaps in stroke care management.
Its latest funding will also go to building new capabilities.
Also, Roche and Astellas have combined their diabetes management solutions.
The company targets to receive a similar clearance from the US FDA by yearend.
It has been approved for use in both clinical and home settings.
It seeks to support and accelerate the development of personalised healthcare and drug discovery.
Also, Jolly Good has collaborated with Brigham and Women's Hospital to create medical education VR content.
It also received backing from the founding members of Grab and Zalora.